Beclometasone • Budesonide • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell stabilizers Cromoglicate • NedocromilXanthines Aminophylline • Theobromine • combivent dosage antagonists Montelukast • Pranlukast • ZafirlukastCombination.

ofIpratropium Muscarinic antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC code combivent dosage ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease combivent dosage and asthma. It is marketed by Boehringer Ingelheim as metered dose combivent dosage (MDI) and nebuliser preparations under the trade combivent dosage Combivent.[hide]v • d • eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • combivent dosage • TerbutalineLong acting ?2-agonists combivent dosage Bambuterol • Clenbuterol • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell.

• Fluticasone/salmeterol • Ipratropium/salbutamolThis pharmacology-related article is a stub. You can help.